As of 2025-07-03, the EV/EBITDA ratio of Apyx Medical Corp (APYX) is -4.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apyx's latest enterprise value is 70.19 mil USD. Apyx's TTM EBITDA according to its financial statements is -14.84 mil USD. Dividing these 2 quantities gives us the above Apyx EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.8x - 23.4x | 21.6x |
| Forward P/E multiples | 23.0x - 23.8x | 23.4x |
| Fair Price | (11.49) - (11.72) | (11.27) |
| Upside | -613.1% - -623.3% | -603.0% |
| Date | EV/EBITDA |
| 2025-06-26 | -4.73 |
| 2025-06-25 | -4.04 |
| 2025-06-24 | -4.79 |
| 2025-06-23 | -4.25 |
| 2025-06-20 | -4.25 |
| 2025-06-18 | -3.66 |
| 2025-06-17 | -3.76 |
| 2025-06-16 | -3.96 |
| 2025-06-13 | -3.74 |
| 2025-06-12 | -3.67 |
| 2025-06-11 | -3.76 |
| 2025-06-10 | -3.88 |
| 2025-06-09 | -3.70 |
| 2025-06-06 | -3.58 |
| 2025-06-05 | -3.56 |
| 2025-06-04 | -3.56 |
| 2025-06-03 | -3.48 |
| 2025-06-02 | -3.48 |
| 2025-05-30 | -3.36 |
| 2025-05-29 | -3.44 |
| 2025-05-28 | -3.58 |
| 2025-05-27 | -3.76 |
| 2025-05-23 | -3.32 |
| 2025-05-22 | -3.56 |
| 2025-05-21 | -3.20 |
| 2025-05-20 | -3.22 |
| 2025-05-19 | -3.22 |
| 2025-05-16 | -3.10 |
| 2025-05-15 | -3.20 |
| 2025-05-14 | -3.06 |
| 2025-05-13 | -3.40 |
| 2025-05-12 | -2.44 |
| 2025-05-09 | -2.55 |
| 2025-05-08 | -2.59 |
| 2025-05-07 | -2.73 |
| 2025-05-06 | -2.37 |
| 2025-05-05 | -2.55 |
| 2025-05-02 | -2.73 |
| 2025-05-01 | -2.37 |
| 2025-04-30 | -2.31 |
| 2025-04-29 | -2.11 |
| 2025-04-28 | -2.03 |
| 2025-04-25 | -2.01 |
| 2025-04-24 | -2.05 |
| 2025-04-23 | -2.03 |
| 2025-04-22 | -2.11 |
| 2025-04-21 | -2.19 |
| 2025-04-17 | -2.18 |
| 2025-04-16 | -2.09 |
| 2025-04-15 | -2.27 |